Immediate Impact

1 from Science/Nature 55 standout
Sub-graph 1 of 23

Citing Papers

Persistent physical symptoms: definition, genesis, and management
2024 Standout
Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials
2022 Standout
2 intermediate papers

Works of Jana Keller being referenced

Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials.
1991
A clinician's guide for conducting randomized trials in individual patients.
1988

Author Peers

Author Last Decade Papers Cites
Jana Keller 223 140 115 11 750
KF Schulz 112 90 64 13 931
A Aïssa Benhaddad 158 96 106 8 893
Guido Skipka 70 70 128 28 838
Gerald van Belle 160 71 142 17 942
Naomi A Mckoy 148 107 57 9 938
Virginia Chiocchia 82 93 61 26 948
Aïda Bafeta 53 76 72 9 803
Saskia Subramanian 384 50 33 9 732
Hans de Beer 86 74 99 16 967
Edward Whalen 154 50 109 11 763

All Works

Loading papers...

Rankless by CCL
2026